APOGEM CAPITAL LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
APOGEM CAPITAL LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$224,000
-21.1%
14,056
-32.0%
0.22%
-13.2%
Q2 2022$284,000
+17.8%
20,669
+35.9%
0.26%
+55.8%
Q1 2022$241,000
+14.2%
15,213
+57.4%
0.16%
+19.6%
Q4 2021$211,0009,6660.14%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$11,354,00010.44%
RTW INVESTMENTS, LP 15,802,802$250,632,0005.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$17,884,0004.03%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,077,0004.02%
Prosight Management, LP 203,268$3,224,0002.08%
COWEN AND COMPANY, LLC 1,000,000$15,860,0001.53%
Boxer Capital, LLC 1,466,051$23,252,0001.20%
Cormorant Asset Management, LP 868,550$13,775,0001.06%
Amitell Capital Pte Ltd 97,331$1,544,0000.90%
SECTORAL ASSET MANAGEMENT INC 303,975$4,821,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders